Inhaled nitric oxide (iNO) use in infants >1500 g, but <34 weeks gestation with severe respiratory failure will reduce the incidence of death and/or bronchopulmonary dysplasia (BPD).
Division of Neonatal and Developmental Medicine, School of Medicine and Lucile Packard Children's Hospital, Stanford University, Palo Alto, CA 94304, USA. vanmeurs@stanford.edu